CareD: Non-Pharmacological Assistance for Dementia Patients
DOI:
https://doi.org/10.4108/eai.13-7-2018.160073Keywords:
Alzheimer’s disease, cognitive therapies, Dementia, Mobile App for Older AdultsAbstract
BACKGROUND: Dementia is a common form of Alzheimer disease which is affecting the quality of older adults’ life. Non-drug treatment such as cognitive therapies are more beneficial for such patients. These days, mobile applications are providing tremendous opportunities for aiding the medicinal treatment.
OBJECTIVES: This paper presents CareD – a mobile application based solution for dementia patients and their caregivers. Unlike, other available mobile applications, CareD provide a single resolution for maximum dementia related complications. The main objective of this application is to improve the quality of life of dementia patients and facilitate their caregivers. CareD also aims at providing native language support i.e. Urdu to the people of Pakistan.
METHODS: CareD comprises of various modules including cognitive therapy sessions, patient tracking, reminders, healthy living to aid dementia patients in their everyday activities. Experimental study involving dementia patients and their caregivers has been carried out to evaluate the usability and effectiveness of this application.
RESULTS: Twenty patients were included in the study. Results showed that CareD is very effective and helpful in decreasing the disease progression as well as in relieving the burden of caregivers.
CONCLUSION: CareD has been found to be a useful and efficient solution for dementia patients. It was observed that utilization of mobile application was progressively successful in reducing the stress of both; patients and their caregivers. The use of native language Urdu made the application more learnable for older adults and improved its acceptance.
Downloads
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 EAI Endorsed Transactions on Pervasive Health and Technology
This work is licensed under a Creative Commons Attribution 3.0 Unported License.
This is an open access article distributed under the terms of the CC BY-NC-SA 4.0, which permits copying, redistributing, remixing, transformation, and building upon the material in any medium so long as the original work is properly cited.